期刊文献+

卡维地洛对慢性充血性心力衰竭患者心功能及心率变异性的影响 被引量:7

The Influences of Carvedilol on Cardiac Function and Heart Rate Variability in Patients with Congestive Heart Failure
原文传递
导出
摘要 目的 观察卡维地洛对慢性充血性心力衰竭 (CHF)患者心功能和心率变异性 (HRV)的影响。方法  63例CHF患者随机分为两组 ,在心衰常规用药的基础上 ,卡维地洛由小剂量开始 ,逐渐递增至目标剂量。治疗前及治疗 6月后测定心功能及HRV指标。结果 治疗 6月后卡维地洛组与对照组比较 ,左室舒张末期内径 (LVEDD)、左室收缩末期内径 (LVESD)显著下降 (P <0 0 5 ) ,左室射血分数 (LVEF)显著增加 (P <0 0 5 ) ;心率变异性指标全部窦性心律R -R间期的标准差 (SDNN) ,全程连续 5minR -R间期标准差的平均值 (SDANN) ,全部相邻R -R间期差值的均方根 (rMSSD) ,相邻RR间期差值 >5 0ms的百分比 (PNN5 0 ) ,低频率段功率 ( 0 0 4~ 0 15Hz) (LF) ,高频率段功率 ( 0 15~ 0 40Hz) (HF)显著增加 ( P <0 0 5 ) ,LF/HF比值显著下降 ( P <0 0 5 )。结论 卡维地洛加心衰常规治疗 ,在改善CHF患者心功能的同时显著改善HRV ,从而改善自主神经的平衡性 。 Objective To observe the effect of carvedilol on cardiac function and heart rate variability(HRV) in patients with congestive heart failure(CHF) . Methods Sixty-three patients with CHF were randomly divided into two groups. 33 cases (carvedilol group) were given Carvedilol titrated from low dose to target dose in addition to standard therapy for CHF. The cardiac fuction and HRV of all patients were examined before and after 6 months therapy. Results After 6-month therapy, LV end-diastolic dimension (LVEDD) and LV end-systolic dimension (LVESD) in carvedilol group were significantly lower than those in control group (P<0 05),and LV ejection fraction (LVEF) was remarkably higher (P<0 05). After treatment, standard deviation of all means of 5-minutes R-R intervals all over 24 hours (SDANN), root mean square of successive R-R differences (rMSSD), percentage of adjacent differences more than apart (PNN50), low frequency (LF), and high frequency (HF) in carvedilol group were obviously higher than those in control group (P<0 05),and LF/HF was remarkably lower (P<0 05). Conclusion Carvedilol may improve cardiac function and HRV in patients with congestive heart failure.
出处 《中国医师杂志》 CAS 2004年第6期800-801,共2页 Journal of Chinese Physician
关键词 卡维地洛 慢性充血性心力衰竭 心功能 心率变异 CHF HRV Heart rate variability Heart failure, congestive Carvedilol
  • 相关文献

参考文献5

  • 1Lu F, Keeling PJ, Gill JS, et al. Heart rate variability and its relation to ventricular arrthyhmias in congestive heart failure[J]. Br Heart J, 1994, 71:322-328 被引量:1
  • 2Packer M. The effect of carvedilon morbidity and mortality in patients with chronic heart failure[J]. N Engl J Med, 1996,334:1349-1355 被引量:1
  • 3Packer M, Coats AJS, Fowler MC, et al. Effect of carvedilol on survival in severe chronic heart failure[J]. N Engl J Med, 2001,344:1651-1658 被引量:1
  • 4Abreu RMV , Santos DJSL, Moreno AJM . Effects of Carvedilol and its analog BM-910228 on mitochondrial function and oxidative stress[J]. J Pharmacol Exp Therapeut, 2000,295:1022-1030 被引量:1
  • 5Von Moellendorff E, Abshagen U, Akpan W, et al. Clinical pharmacologic investigations with carvedilol, a new β-blocher with direct vasodilator activity[J]. Clin Pharmacol Ther, 1986,39:677-682 被引量:1

同被引文献53

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部